Opinion

Video

Examining the Role of Liver Function in HCC

Author(s):

Richard Finn, MDDavid James Pinato, MD, MRCP, PhD

Richard Finn, MD, and David James Pinato, MD, MRCP, PhD, discuss driving forces for the development of hepatocellular carcinoma, including different types of viral hepatitis and non-alcoholic steatohepatitis.

Related Videos
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
Related Content
Arndt Vogel, MD
June 2nd 2024

First-Line Camrelizumab Plus Rivoceranib Maintains Survival Benefit in Unresectable HCC

Stephanie L. Graff, MD, director, Breast Oncology, Lifespan Cancer Institute, associate professor, medicine, Brown University; Reshma L. Mahtani, DO, medical oncologist, Miami Cancer Institute, chief, Breast Medical Oncology, Baptist Health’s Wellness and Medical Complex; Kelly E. McCann, MD, PhD, breast medical oncologist, assistant clinical professor, medicine, the University of California, Los Angeles Health David Geffen School of Medicine; Hope S. Rugo, MD, Winterhof Family Endowed Professor in Breast Cancer, the University of California San Francisco (UCSF), professor, medicine, Division of Hematology and Oncology, director, Breast Oncology, director, Clinical Trials Education, director, Cancer Infusion Services, the UCSF Helen Diller Family Comprehensive Cancer Center
April 11th 2024

Breast Cancer Experts Share Obstacles and Successes as Women in Oncology

Carol M. Mangione, MD, of UCLA Health
May 16th 2024

Updated Breast Cancer Screening Recommendations Pave the Way for a More Equitable Future

Zev A. Wainberg, MD, professor, medicine, the University of California, Los Angeles (UCLA), codirector, the UCLA Gastrointestinal Oncology Program
March 11th 2024

FDA Approval Insights: NALIRIFOX in Metastatic Pancreatic Cancer

Gottfried E. Konecny, MD, medical oncologist, Department of Gynecologic Medical Oncology, lead clinician, gynecologic oncology, University of California, Los Angeles, UCLA Health Jonsson Comprehensive Cancer Center
April 29th 2024

PROs Underscore Utility of Mirvetuximab Soravtansine in FRα+ Ovarian Cancer

John D. Gordan, MD, PhD
April 29th 2024

ASCO Updates Advanced HCC Treatment Guideline